Severity of Illness Index
"Severity of Illness Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
Descriptor ID |
D012720
|
MeSH Number(s) |
E05.318.308.980.438.475.456.500 N05.715.360.300.800.438.375.364.500 N06.850.520.308.980.438.475.364.500
|
Concept/Terms |
Severity of Illness Index- Severity of Illness Index
- Illness Index Severities
- Illness Index Severity
- Index Severities, Illness
- Index Severity, Illness
|
Below are MeSH descriptors whose meaning is more general than "Severity of Illness Index".
Below are MeSH descriptors whose meaning is more specific than "Severity of Illness Index".
This graph shows the total number of publications written about "Severity of Illness Index" by people in this website by year, and whether "Severity of Illness Index" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 4 | 4 |
1995 | 0 | 4 | 4 |
1996 | 2 | 8 | 10 |
1997 | 2 | 12 | 14 |
1998 | 0 | 9 | 9 |
1999 | 1 | 16 | 17 |
2000 | 1 | 18 | 19 |
2001 | 2 | 23 | 25 |
2002 | 1 | 35 | 36 |
2003 | 5 | 40 | 45 |
2004 | 5 | 34 | 39 |
2005 | 3 | 38 | 41 |
2006 | 0 | 61 | 61 |
2007 | 4 | 60 | 64 |
2008 | 6 | 59 | 65 |
2009 | 3 | 74 | 77 |
2010 | 5 | 60 | 65 |
2011 | 6 | 69 | 75 |
2012 | 9 | 55 | 64 |
2013 | 9 | 64 | 73 |
2014 | 8 | 56 | 64 |
2015 | 9 | 65 | 74 |
2016 | 9 | 69 | 78 |
2017 | 6 | 75 | 81 |
2018 | 10 | 74 | 84 |
2019 | 7 | 76 | 83 |
2020 | 7 | 71 | 78 |
2021 | 3 | 52 | 55 |
2022 | 0 | 12 | 12 |
2023 | 0 | 13 | 13 |
2024 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.
-
Bimekizumab for the treatment of psoriasis. Immunotherapy. 2024 Apr; 16(7):431-446.
-
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials. Br J Dermatol. 2024 Mar 15; 190(4):477-485.
-
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension. J Crohns Colitis. 2024 Feb 26; 18(2):264-274.
-
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial. JAMA Dermatol. 2024 Feb 01; 160(2):204-209.
-
External validation of the modified sepsis renal angina index for prediction of severe acute kidney injury in children with septic shock. Crit Care. 2023 11 28; 27(1):463.
-
A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index. J Crohns Colitis. 2023 Nov 24; 17(11):1733-1743.
-
Variation in Reader-Reported Severity of Paradoxical Low-Flow Low-Gradient Aortic Stenosis. J Am Soc Echocardiogr. 2024 Apr; 37(4):466-467.
-
Doppler Echocardiographic Phenotypes in Suspected 'Severe' Aortic Stenosis: Matrix-Based Approach to Diagnosis and Management. J Am Soc Echocardiogr. 2024 Mar; 37(3):307-315.
-
Model for End-Stage Liver Disease 3.0: One step forward to mitigate sex and gender disparities in liver transplant. Am J Transplant. 2024 Jan; 24(1):145-146.
-
Hidradenitis suppurativa perspectives during the COVID-19 pandemic. Clin Dermatol. 2023 Sep-Oct; 41(5):622-627.